The emerging landscape of engineered bacteria cancer therapies

1. Forbes, N. S. Nat. Rev. Cancer 10, 785–794 (2010).

   CAS 
   PubMed 
   PubMed Central 
   
   Google Scholar 

2. Zhou, S., Gravekamp, C., Bermudes, D. & Liu, K. Nat. Rev. Cancer 18, 727–743 (2018).

   CAS 
   PubMed 
   PubMed Central 
   
   Google Scholar 

3. Duong, M. T.-Q., Qin, Y., You, S.-H. & Min, J.-J. Exp. Mol. Med. 51, 1–15 (2019).

   CAS 
   PubMed 
   
   Google Scholar 

4. Sieow, B. F.-L., Wun, K. S., Yong, W. P., Hwang, I. Y. & Chang, M. W. Trends Cancer 7, 447–464 (2021).

   CAS 
   PubMed 
   
   Google Scholar 

5. Lynch, J. P., Goers, L. & Lesser, C. F. Trends Pharmacol. Sci. 43, 772–786 (2022).

   CAS 
   PubMed 
   PubMed Central 
   
   Google Scholar 

6. Kwon, S.-Y., Thi-Thu Ngo, H., Son, J., Hong, Y. & Min, J.-J. Nat. Rev. Clin. Oncol. 21, 569–589 (2024).

   PubMed 
   
   Google Scholar 

7. Chien, T., Doshi, A. & Danino, T. Curr. Opin. Syst. Biol. 5, 1–8 (2017).

   PubMed 
   PubMed Central 
   
   Google Scholar 

8. Nejman, D. et al. Science 368, 973–980 (2020).

   CAS 
   PubMed 
   PubMed Central 
   
   Google Scholar 

9. Waldman, A. D., Fritz, J. M. & Lenardo, M. J. Nat. Rev. Immunol. 20, 651–668 (2020).

   CAS 
   PubMed 
   PubMed Central 
   
   Google Scholar 

10. Hobohm, U. Cancer Immunol. Immunother. 50, 391–396 (2001).

    CAS 
    PubMed 
    PubMed Central 
    
    Google Scholar 

11. Quispe-Tintaya, W. et al. Proc. Natl Acad. Sci. USA 110, 8668–8673 (2013).

    CAS 
    PubMed 
    PubMed Central 
    
    Google Scholar 

12. Warren, H. S. et al. J. Infect. Dis. 201, 223–232 (2010).

    CAS 
    PubMed 
    
    Google Scholar 

13. Toso, J. F. et al. J. Clin. Oncol. 20, 142–152 (2002).

    PubMed 
    
    Google Scholar 

14. Nemunaitis, J. et al. Cancer Gene Ther. 10, 737–744 (2003).

    CAS 
    PubMed 
    
    Google Scholar 

15. Yang, S. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-024-02418-6 (2024).

    Article 
    PubMed 
    PubMed Central 
    
    Google Scholar 

16. Vincent, R. L. et al. Science 382, 211–218 (2023).

    CAS 
    PubMed 
    PubMed Central 
    
    Google Scholar 

17. Wang, W. et al. Nat. Biomed. Eng. 6, 44–53 (2022).

    CAS 
    PubMed 
    
    Google Scholar 

18. Cronin, M. et al. Mol. Ther. 22, 1188–1197 (2014).

    CAS 
    PubMed 
    PubMed Central 
    
    Google Scholar 

19. Singer, Z. S., Pabón, J., Huang, H., Rice, C. M. & Danino, T. Preprint at bioRxiv https://doi.org/10.1101/2023.09.28.559873 (2023).

20. Khanduja, S. et al. iScience 27, 109813 (2024).

    CAS 
    PubMed 
    PubMed Central 
    
    Google Scholar 

Download references

Author notes

1. Rosa L. Vincent

   Present address: Center for Gene Therapy, Baylor College of Medicine, Houston, TX, USA

2. These authors contributed equally: Edward R. Ballister, Alexander Michels, Rosa L. Vincent.

Authors and Affiliations

1. Department of Biomedical Engineering, Columbia University, New York, NY, USA

   Edward R. Ballister, Alexander Michels, Rosa L. Vincent, Lior Kreindler, Sreyan Chowdhury & Tal Danino

2. Department of Microbiology and Immunology, Vagelos College of Physicians and Surgeons of Columbia University, New York, NY, USA

   Edward R. Ballister

3. Cancer Research Institute, New York, NY, USA

   Samik Upadhaya & Ana Rosa Saez-Ibañez

4. Google Research, Mountain View, CA, USA

   Tao Tu & Juraj Gottweis

5. Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA

   Tal Danino

6. Data Science Institute, Columbia University, New York, NY, USA

   Tal Danino

Corresponding author

Correspondence to
Tal Danino.

Competing interests

T.D. and S.C. have a financial interest in GenCirq Inc.